Matthew Miller Wins the Satinder Ahuja Award for Young Investigator in Separation Sciences
The Satinder Ahuja Award for Young Investigator in Separation Sciences has been presented to Matthew Miller, Technical Leader at Dow Chemical in the Analytical Science Core R&D group, at Pittcon 2016.
The 2016 Satinder Ahuja Award for Young Investigator in Separation Sciences has been presented to Matthew Miller, Technical Leader at Dow Chemical in the Analytical Science Core R&D group. The award was presented at Pittcon 2016, held this year in Atlanta, Georgia, USA.
Miller won the award for his work in the development of graphite-mediated compositional polyolefin separations. Graphitic-carbon-based separation phases interact with amorphous polyolefins, a previously difficult to separate material. This difficulty results from the lack of a discrimination mechanism. The invention of graphitic-carbon-based separations has now enabled separation to occur and led to an understanding of the full range of ethylene and alpha-olefin comonomer content.1
Formerly the ACS Division of Analytical Chemistry for Young Investigators in Separation Sciences Award, the award has since been renamed the Satinder Ahuja Award for Young Investigator in Separation Sciences, and was created to recognize and encourage outstanding contributions to the field of separation science by a young chemist or chemical engineer.
Before joining Dow Chemical in 2005, Miller attended Michigan State University receiving a Ph.D. in analytical chemistry and earned a B.S. in chemistry from Saginaw Valley State University. He is the joint inventor on four patents and has co-authored 14 research articles.
Reference
- M.D. Miller et al., J. Appl. Polym. Sci123(2), 1238–1244 (2012).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
